Header cover image

U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

UPDATED Nov 30, 2022

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

3 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
ABCLAbCellera BiologicsUS$12.87-8.1%-11.7%US$3.7bUS$29.33PE14.8xE-59.6%n/a
AVIRAtea PharmaceuticalsUS$4.690%-40.0%US$390.6mUS$10.50PE11xE-17.7%n/a
Page 1 of 1